Role of Levonorgestrel Intrauterine System (LNG-IUS) in the Management of Abnormal Uterine Bleeding (AUB): A Conservative Approach to Preserve the Uterus.

BACKGROUND

Abnormal uterine bleeding (AUB), particularly heavy menstrual bleeding (HMB), significantly impairs women's health and quality of life. Levonorgestrel intrauterine system (LNG-IUS) offers a uterus-sparing alternative to surgical interventions.

OBJECTIVE

To evaluate the efficacy and safety of LNG-IUS in the long-term management of AUB unrelated to intrauterine pathology.

MATERIALS AND

METHODS

A prospective observational study was conducted on 30 parous women aged 33-48 years with recurrent HMB. LNG-IUS was inserted within 7 days of menstruation onset, and patients were followed at 1, 3, 6, 12, and 24 months. Bleeding intensity and side effects were recorded.

RESULTS

Out of 30 patients, 21 (70%) reported a significant reduction in bleeding. Only 9 patients (30%) required a hysterectomy. Mild side effects were reported in 33.3% of cases.

CONCLUSION

LNG-IUS is an effective, well-tolerated, long-term treatment for AUB and can reduce the need for hysterectomy.